L38- NSAIDs Flashcards

1
Q

define NSAIDs and indicate prototype

A

group of drugs involved in antipyretic, analgesic, anti-inflammatory activity

ASA / aspirin is prototype

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

(1) is the main source of eicosanoids, with (2) as the structural elements. It is converted from cell membrane to (1) by (3), which can be inhibited by (4) drugs.

A

1- arachidonic acid
2- 20C unsaturated FA with 4 double bonds

3- PLA2
4- steroids (inhibition, downregulation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

NSAIDs generally inhibit ______ reaction / cascade- include all components

A

COX-1/2 = cyclooxygenase

-arachidonic acid —-> Prostaglandins: prostacyclin, thromboxanes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

arachidonic acid is converted to LTs via ______

A

lipoxygenases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

(1) = prostacyclin

(2) is the main thromboxane

A

1- PG-I2

2- TX-A2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

______ is mainly responsible for fever and pain responses, include brief mechanism

A

PG-E2:

  • Fever via hypothalamus / anterior pituitary pathway
  • Pain via sensitization of peripheral nerves to pain stimulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

COX-1:

  • (constitutive/inducible) enzyme
  • (2) main location
  • (3) main function
  • major source of (4)
A

1- constitutive
2- gastric epithelium, platelets
3- tissue homeostasis
4- cytoprotective PG formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

COX-2:

  • (constitutive/inducible) enzyme, (2) is the exception
  • major source of (3) and (4)
A

1- inducible via GFs, tumor promoters, CKs
2- constitutive in brain, kidneys

3- eiconasoids in cancer / inflammation
4- prostacyclin (PG-I2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

anti-inflammatory of NSAIDs mostly results from action on COX-(1/2) inhibition

A

COX-2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

gastric damage from NSAIDs results from ______ actions

A

COX-1 inhibition + direct irritation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

list the all the NSAIDs

A

Selectives (for COX-2): celecoxib, meloxicam

Non-Selectives (PAINKID): piroxicam, aspirin, ibuprofen, naproxen, ketorolac, indomethacin, diclofenac

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

______ is the main specific use for NSAIDs

A

mild-to-moderate pain: especially inflammatory pain, eg. MSK disorders (RA, OA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

list the two main uses of aspirin beyond its NSAID activity, explain (hint- not post-MI use)

A

1) 50% dec in colon cancer risk

2) adjunct with Niacin (anti-dyslipidemia, lows serum cholesterol) in order to prevent PG mediated intense flushing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

______ can be used to close persistent PDA in neonatal life (drug of choice)

A

indomethacin

note- ibuprofen has shown to have equal efficacy and safety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

list the main systems that NSAID AEs mostly affect

A
  • GI
  • renal
  • CVS
  • respiratory (NERD)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

describe the main GI AE with NSAID use, include mechanism

A

Ulceration:
1) inhibition of COX-1 –> dec in protective components for GI lining (seen in non-selective NSAIDs)

2) direct local irritation of gastric mucosa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

to prevent GI AEs, NSAIDs can be co-administered with….

A

misoprostol (PG-E1)
PPIs
H2R blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

______ has highest risk for GI AEs with NSAID use, ______ has the lowest risk

A

high- Piroxicam (non-selective)

low- celecoxib (COX-2 selective)

19
Q

describe the main CVS AE with NSAID use, include mechanism and if more in selective or non-selective NSAIDs

A

Mostly selective NSAIDs, celecoxib > meloxicam in terms of COX-2 selectivity:

  • Platelets (COX-1) –> inc TX-A2 (selective) –> vasoconstriction, platelet aggregation
  • Endothelial cells can replenish COX-2, but still overall –> dec PG-I2 –> dec vasodilation, dec inhibition of platelet aggregation

=> thrombosis formation —> inc risk of MI, CVA, death

20
Q

compare GI and CVS AEs between selective and non-selective NSAIDs

A

selective: mostly GI issues via COX-1 inhibition

non-selective / coxibs: mostly CVS via only COX-2 inhibition

21
Q

list the two major adverse renal effects from NSAIDs

A
  • dec renal blood flow

- analgesic nephropathy

22
Q

describe mechanism of decreased renal blood flow from using NSAIDs

A

Normal Situations:

  • PGs dilate afferent arterioles => inc RBF
  • Angiotensin II (AGII) constricts efferent arterioles –> inc RBF

CHF / CKD Pts:

  • inc PGs are more important than AGII at maintaining RBF/GFR
  • *-if given NSAID –> dec PGs => dec RBF
23
Q

prolonged and excessive use of NSAIDs may lead to….

A

chronic interstitial nephritis —- papillary necrosis

**use acetaminophen

24
Q

______ is the NSAID that most commonly causes hypersensitivity reactions, explain

A

Celecoxib- contains Sulfonamide –> rxn via allergy

25
NSAID effects on respiratory system: - inc in (1) causes (2) response in lungs and (3) symptoms - inc in (4) causes (5) response in lungs and (6) symptoms
NERD: NSAID exacerbated respiratory disease 1/2/3- inc LT-C4, LT-B4 --> bronchoconstriction: -wheezing, dyspnea 4/5/6- inc LT-C4, LT-B4 --> vasodilation: - flushing, hypotension, shock - vasomotor rhiniti, angioedema, urticaria
26
list the drugs that are most concerning when used with NSAIDs
ACE inhibitors corticosteroids warfarin
27
describe the effect of ACE inhibitors and NSAIDs when co-administered
ACEI alone: - dec angiotensin II - dec inactivation of bradykinin => inc PGs --> vasodilation + dec BP ACEI w/ NSAID --> dec PG production --> diminishes effects of ACEIs
28
describe 'triple whammy' drug interactions
Triple Whammy: ACEI + diuretic + NSAID => acute renal injury - NSAID --> dec PG => afferent vasoconstriction --> dec GFR - ACEI --> dec AG II => efferent vasodilation --> dec GFR - diuretic --> dec plasma volume --> dec GFR
29
______ is the main risk with using NSAIDs + corticosteroids
inc risk of GI ulceration: | -do not take on empty stomach if they must be taken together
30
______ is the main risk with using NSAIDs + warfarin
inc risk of bleeding- especially in susceptible patients (von Willebrand's, hemophilia)
31
list and explain the contraindications for NSAIDs (hint- 2)
1) children/young adults (no ASA or salicylate derivatives): -Reye's syndrome = fever + viral-like illness (use acetaminophen) 2) pregnancy, especially near term - may cause premature PDA closure
32
list the salicyclates
ASA magnesium choline salicylate sodium salicylate salicyl salicylate
33
______ is the major unique feature of ASA compared to other salicylates
irreversible inhibition of COX-1/2
34
ASA is metabolized into (1), which may cause (2) casade depending on dosage
1- ASA --> **salicylate + acetic acid 2- salicyclare is oxidative phosphorylation uncoupler: i) inc CO2 ii) at high doses, inc CO2 => hyperventilation iii) at toxic doses, over stimulation of ventilation => desensitization --> hypoventilation
35
ASA has a (1) effect on platelets, lasting for (2) duration and having (3) as main result
1- irreversible inhibition of COX-1 2- 5-7 days = platelet lifespan 3- dec TX-A2 (usually vasoconstriction + platelet aggregation) => prolonged bleeding time Note- endothelial cells are not as affected at low doses b/c they can make their own COX enzymes
36
describe the relative effects of each of the following on PG-I2/prostacyclin levels and TX-A2 levels: - (1) low dose ASA - (2) convention NSAIDs - (3) COX-2 inhibitors
1- slight dec PG-I2, major dec TX-A2 2- major dec in PG-I2 and TX-A2 3- major dec PG-I2, no effect TX-A2
37
ASA: - (1) major clinical use - (2) CVS use
1- mild to moderate pain: RA and other anti-inflammatory + antipyretic 2- cardioprotective --> inhibits platelet aggregation at low doses
38
list the effects of ASA as dose increases
- low dose 81mg, antiplatelet - moderate dose 650-1000mg, antipyretic + analgesic - high doses 1-6g, anti-inflammatory + tinnitus - 6-10g, hyperventilation / respiratory alkalosis - 10-20g, fever, dehydration, metabolic acidosis - 20-30g, shock, coma, respiratory / renal failure, death
39
describe the metabolism of ASA
<1g, first-order kinetics; half-life 3.5hrs >1g, zero-order kinetics metabolized by liver --> metabolites excreted by urine
40
list the many AEs of ASA
- GI distress (ulceration) - prolonged bleeding time - Reye's syndrome (young people) - hypersensitivity - hepatic injury at high doses - anti-uricosuric effect (inc serum uric acid) - salicylism
41
describe the anti-uricosuric effect
with use of ASA: - uric acid is excreted into renal tubule via OAT (organic acid transporter) - ASA competes with uric acid for OAT - dec uric acid secretion - hyperuricemia (avoid use in gout Pts)
42
(1) describe salicylism | (2) describe acute salicylate intoxication
1- (mild chronic salicylate intoxication) HA, dizziness, tinnitus, mental confusion, hyperventilation 2: - mixed respiratory alkalosis and metabolic acidosis - respiratory failure is usual cause of death - circulatory collapse may occur
43
Acetaminophen is a metabolite of (1) and its MOA is (2), giving it (3) activity in terms of clinical use, but not (4).
1- phenacetin 2- weak COX-1/2 inhibitor 3- analgesic, antipyretic 4- anti-inflammatory
44
______ may accumulate in acetaminophen overdose
NAPQI = N-acetyl-p-benzoquinone imine